| Patient | Martin Luther King |
|---|---|
| Date of birth | 1990-01-15 |
| Identifiers | MRN HR-ML001-SYN; SSN (made up) 000-01-4058 |
| Document date | 2026-09-15 |
| Author | Cornelius Ashby-Nwankwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Twenty-three-week review: remission, smoking, blood pressure and lipids. [S]
Dr. King returns six weeks after a bronchitis, which settled in about two weeks without an antibiotic; he did not smoke through it. He has been smoke-free since the June lapse and is five weeks into the second course of varenicline. His mood has been good for over a month, he sleeps about seven hours, and therapy is now monthly. He has kept most of his work plan, though the autumn schedule is heavier. Home readings averaged 128/82. He has lost about a kilogram. He has no thoughts of harming himself. [S]
| Element | Detail |
|---|---|
| Bronchitis | Settled in about two weeks; no smoking |
| Smoking | Smoke-free since June; second varenicline course |
| Mood | Good; PHQ-9 4 |
| Home blood pressure | Average 128/82 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good |
| Respiratory | Negative | No cough |
| Cardiovascular | Negative | Scar aching rare; no chest pain on exertion |
| Psychiatric | Negative | Mood good; sleep seven hours; no suicidal ideation |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg tablet, one by mouth once daily for 3 days, then twice daily for 4 days | once daily for 3 days, then twice daily for 4 days, after food | Oral route | 2026-05-12 to 2026-05-19 | completed | S |
| Varenicline 1 mg tablet, one by mouth twice daily after food | twice daily after food | Oral route | 2026-05-19 | active | S |
| Acetaminophen 500 mg tablet, one or two by mouth every 6 hours as needed for chest-wall aching with the cough, no more than 3,000 mg a day | every 6 hours as needed, at most 3,000 mg a day | Oral route | 2026-08-04 to 2026-08-18 | completed | S |
| Sertraline 25 mg tablet, one by mouth each morning for one week | once daily in the morning | Oral route | 2026-04-20 to 2026-04-27 | completed | S |
| Sertraline 50 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 2026-04-27 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-15 | Body height | 170 | cm | S |
| 2026-09-15 | Body weight | 82.8 | kg | S |
| 2026-09-15 | Body mass index (BMI) [Ratio] | 28.7 | kg/m2 | S |
| 2026-09-15 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-09-15 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-09-15 | Heart rate | 70 | /min | S |
| 2026-09-15 | Respiratory rate | 14 | /min | S |
| 2026-09-15 | Body temperature | 36.6 | Cel | S |
| 2026-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-15 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-09-15 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | Below 200 | Normal | S |
| 2026-09-15 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | Below 150 | Normal | S |
| 2026-09-15 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 45 | mg/dL | 40 or more | Normal | S |
| 2026-09-15 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 127 | mg/dL | Below 130 | Normal | S |
Vital signs recorded on 2026-09-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Blood pressure 128/82, pulse 70; weight 82.8 kg, BMI 28.7 |
| Respiratory | Clear |
| Psychiatric | Euthymic; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Exhaustion, broken sleep and low mood for about two months, under sustained threats and a punishing schedule, after an admission for exhaustion and a respiratory infection six months ago; cause not established at intake: a depressive disorder, an adjustment disorder, PTSD, an insomnia disorder, thyroid disease and anemia to be assessed; psychiatry consultation requested | resolved | confirmed | R53.83 | S — Synthetic presenting problem anchored to his documented admission for exhaustion and the threats against him; superseded by the diagnoses at the second visit. |
| Major depressive disorder, single episode, moderate (DSM-5-TR), arising under chronic threat, surveillance and overwork; no suicidal ideation; PTSD not present on screening and interview | active | confirmed | F32.1 | S — Synthetic modern diagnosis made at the psychiatry consultation, linked to his documented exhaustion and threats and to biographers' accounts of depression (R); not a claim that he was so diagnosed. |
| Insomnia disorder (DSM-5-TR), comorbid with depression: trouble falling and staying asleep at least four nights a week for over three months, with short sleep from late-night work and travel | active | confirmed | G47.00 | S — Synthetic modern diagnosis made at the psychiatry consultation. |
| Nicotine dependence, cigarettes: about a pack a day since his twenties, smoked out of public view | active | confirmed | F17.210 | S — Synthetic modern problem anchored to the documented account of his heavy, hidden smoking. |
| Elevated blood pressure readings in the clinic (138/88 mmHg) without a diagnosis of hypertension; home monitoring to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding; superseded by the diagnosis at the six-week visit. |
| Healed stab wound of the left chest, repaired by thoracotomy seven years ago; occasional aching along the scar with coughing and in cold weather, without exertional or ischemic features | active | confirmed | Z87.828 | S — Synthetic modern problem anchored to his documented stabbing and chest surgery in 1958. |
| Acute bronchitis after a cold, in a man eleven weeks off cigarettes; no pneumonia; managed without antibiotics; resolved | resolved | confirmed | J20.9 | S — Synthetic acute problem; not a historical claim. |
| Stage 1 hypertension (2017 ACC/AHA), confirmed by home readings averaging 136/86 mmHg; no end-organ damage (normal ECG, urine albumin, kidney function and fundi); low estimated 10-year risk; lifestyle treatment | active | confirmed | I10 | S — Synthetic modern diagnosis made at the eight-week visit; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | At least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 4, from 17: remission |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation since the last visit; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Medication safety | Adherence and adverse-effect review | Every visit | Completed today | No missed doses of sertraline or varenicline; no side effects |
| Self-management | Smoking status after the quit date | Every visit | Completed today | Smoke-free since June, including through the bronchitis |
| Survey | Insomnia Severity Index and sleep diary | Every visit during CBT for insomnia | Completed today | Insomnia Severity Index 7; about seven hours a night (score in the notes; no LOINC code used) |
| Examination | Home blood pressure readings | A week before each visit while treatment is adjusted | Completed today | Seven-day average 128/82 |
| Examination | Office blood pressure, weight and BMI | Every visit | Completed today | 128/82 mmHg; weight 82.8 kg, BMI 28.7 |
| Laboratory | Lipid panel | At diagnosis of hypertension; repeat after lifestyle change; then yearly | Completed today | LDL 127 mg/dL, HDL 45 mg/dL, triglycerides 120 mg/dL |
| Laboratory | Basic metabolic panel and urine albumin | Yearly when not on blood pressure medicine | Up to date | Normal at intake and at eight weeks |
| Self-management | Sustainable work plan: a day off each week, two speeches a day at most, sleep window kept | Every visit | Completed today | Kept on most weeks; heavier autumn schedule discussed |
Goal progress:
Guideline basis: Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017); 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (2018)
Follow-up: Review in three months. Therapy monthly. [S]